We are strategically positioned at key junctions in the drug development pipeline to leverage our collective resources and knowledge for greatest impact. From catalytic funding to intensive research collaborations to advocating for policies that impact those affected, we’re ensuring change on every level.
We recognize our generous corporate and foundation partners, whose contributions have helped us make major progress in 2014 and 2015.
Together, we are more powerful than brain tumors. Arm yourself with facts about symptoms, treatments, and clinical trials, and access helpful resources and tools for patients and caregivers.
Learn about our integrated programs in research, public policy and advocacy, read event highlights, and stay informed about other news relevant to the brain tumor community.